Full Time MBA
For professionals looking to advance their careers in the ever-evolving medical industry, strong business acumen is critical. The Carlson MBA Program offers a specialized curriculum, access to a thriving community of medical industry employers, and opportunities to partner with the full spectrum of healthcare service providers, from device manufacturers to hospitals and everything in between, to solve emerging healthcare challenges.
Further details regarding the Medical Industry Specialization (126.75 KB)
Connect to an employer pool that exemplifies the wide range of opportunities in modern healthcare. The Medical Industry MBA is designed for professionals looking to break into or advance careers in medical devices, pharmaceuticals, insurance, finance, marketing, consulting, operations, hospitals, and an array of additional medical industries. Carlson MBA students engage with employers starting in year one of the program.
The Graduate Business Career Center (GBCC) at the Carlson School connects outstanding future business leaders with organizations across industries, sectors, and locations. The following are among the wide array of medical industry employers that recruit talent from the Carlson School:
- Mayo Clinic
- Boston Scientific
- GE Healthcare
- UnitedHealth Group
- St. Jude Medical
The Medical Industry MBA provides a tailored, timely curriculum for emerging leaders looking to gain hands-on experience in functional areas of the medical industry.
Focusing on the unique characteristics of the pharmaceutical industry, including its market, regulation, and policy issues, this course leverages interdisciplinary perspectives and industry leader involvement to develop student skill sets. (Spring - B term, 5:45-9:05 p.m.)
This course will survey fundamental healthcare laws that apply to a wide variety of healthcare businesses, and will assess their impact on those business’s strategy and operations. The goal is to enable current and prospective managers and leaders in the healthcare space to be aware of and thus able to proactively manage potential legal issues. (Spring - B term, 5:45-9:05 p.m.)
This course provides a theoretical and conceptual base for managers, creators, and evaluators of health care information technology, including the application of current and evolving technology systems. Special attention is paid to the design and evaluation of common data structures. (Fall - B Term, 5:45 -9:05 p.m.)
Leaders from UnitedHealth Group, Medtronic, and the Mayo Clinic participate in this hands-on experience in creating a value proposition for new medical technologies. This course is also offered as a 2 cr. undergraduate seminar (MILI 5589) (Spring, 3:45-5:25 p.m.)
This course, with the insight of industry leaders, addresses public-private sector interactions and the business, public policy, regulatory, and technology management issues that concern medical device and biotechnology companies. (Fall, 5:45-8:15 p.m.)
Survey of multitrillion dollar medical industry, this course covers physician and hospital services, insurance, pharmaceuticals, medical devices, information technology, and industry scale, interactions, opportunities, and barriers. This course is also offered as a 2 cr. undergraduate seminar (MILI 5990). (Spring - A Term, 5:45 -9:05 p.m.)
A basic overview of the medical vocabulary and physiology of major body systems for non-clinician managers, this course helps medical industry leaders gain facility with clinical practice and medical technology innovations. (Spring - B Term, 5:45-9:05 p.m.)
Understand the various sites of healthcare delivery that exist in order to analyze how the components along the care continuum, currently fit together and more importantly explore how they can be reconfigured and re-engineered to create value. (Fall B - Term, 5:45-9:05 p.m.)
Hands on experience in succinctly evaluating the value of a new technology by considering market size and potential, intellectual property, and return on investment. Intercollegiate teams create rapid production market analysis of promising medical technologies and services to determine potential for success in market. Teams consist of students from Carlson, CLA, CSE and AHC. Exposure to University innovations, venture firms, inventors. This course is also offered by application only as a 2 cr. undergraduate semester-long seminar (MILI 5995) (Fall/Spring/Summer 5:45-9:05 p.m.)
Carlson Medical Industry MBA students participate in the Medical Industry Valuation Laboratory, a unique opportunity to perform a market analysis for a new medical technology with the potential to benefit lives. This 2-credit course groups graduate students across the University of Minnesota into teams and challenges students to analyze market size; evaluate technical, business, preliminary intellectual property, and regulatory challenges; and develop a recommendation for continuing product development or market feasibility.
Medical Industry Leadership Institute
The Medical Industry Leadership Institute is a first of its kind: an academic think tank bridging the education of the next generation of health care leaders and the expertise of today’s executives. It connects executives, physicians, students, and academic leaders with the latest trends in the medical industry, shaping the next generation of leaders. MILI guides the future of the medical industry and drives innovation through cutting-edge leadership education, research, and market development.
"I want to capitalize on my passion for science and business, and with the Medical Device nexus that exists here in Minnesota, the MBA/MILI is hands down the best opportunity that I can pursue. With our existing ties to our Industry Council and the passion that Steve Parente brings to MILI, I can only imagine what the future of this degree will bring. It's really assuring to know that large corporations recognize the value that this specialization affords."
Anil Asrani, 2009 MBA